Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

GI197111X is best dissolved in Capmul MCM for trials.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Human liver enzyme DHEA ST helps process minoxidil.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Certain Dibenzo derivatives may help treat prostate cancer.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Topical DHEA safely increases skin oil production.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Androgens and DHEA can help prevent breast cancer and improve health in women.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.